All posts by : chebby

• Tell us about a healthcare program, within your practice. What are the costs and projected outcomes of this program?
• Who is your target population?
• What is the role of the nurse in providing input for the design of this healthcare program? Can you provide examples?
• What is your role as an advocate for your target population for this healthcare program? Do you have input into design decisions? How else do you impact design?
• What is the role of the nurse in healthcare program implementation? How does this role vary between design and implementation of healthcare programs? Can you provide examples?
• Who are the members of a healthcare team that you believe are most needed to implement a program? Can you explain why?

The purpose of this assignment is to develop a presentation for your capstone project change proposal that you will present in Topic 10 to leaders and interprofessional stakeholders at your practicum site.

Prepare a presentation using as a guide the Topic 8 “Benchmark – Capstone Project Change Proposal” that was completed previously.

Students will disseminate this presentation to leadership at the practicum site in Topic 10. Reach out to your preceptor to collaborate on confirming a date and time to present this PowerPoint to an interprofessional audience of leaders and stakeholders at the practicum site.

Prepare a 10-15-slide PowerPoint presentation of your capstone project change proposal to include the following:

1. Identify the clinical problem statement and explain the purpose of the evidence-based change proposal.
2. Summarize the evidence/literature, including connection to the proposed plan.
3. Propose an implementation plan with an intervention and outcome measures.
4. Outline the roles and responsibilities of the various interprofessional stakeholders who will be needed in order to implement the plan. Roles and responsibilities discussed should be specific to the implementation of your proposed project.
5. Describe the resources needed for project implementation.
6. Discuss the evaluation plan for proposed nursing intervention.

Provide a minimum of three references to accompany in-text citations used throughout the PowerPoint presentation.

In preparing your presentation, consider the stakeholders who will be part of your audience and ensure you incorporate appropriate messaging and communication strategies for that audience. Submit the presentation in the digital classroom for feedback from the instructor.

Title slide and reference slide are not included in the slide count. Include speaker notes below each content-related slide that represent what would be said if giving the presentation in person. Expand upon the information included in the slide and do not simply restate it. Please ensure the speaker notes include a minimum of 50-100 words per slide.

#1

I will be appraising the article titled COVID-19 vaccine effectiveness of booster doses against delta and omicron variants over follow-up times using longitudinal meta-analysis. The study design is a longitudinal meta-analysis as it follows and analyzes data over a period of time. Introduction to quantitative research states, “Longitudinal designs gather data about subjects at more than one point in time” ( Galen College of Nursing, 2024). Researchers extracted data from eighty studies from multiple reliable databases. Analysis was performed on unvaccinated and vaccinated groups that had completed the two doses of the vaccine for delta and omicron. Eighty studies provide a large amount of data and an appropriate sampling size for a meaningful study. The Independent variable is the COVID-19 vaccine booster dose, and the dependent variable is vaccine effectiveness. The data that was surveyed came from reliable databases, and an analysis was performed by two independent researchers, with a third researcher who could be consulted if needed. The main result of the study showed a decreased effectiveness over time, as stated in COVID-19 vaccine effectiveness of booster doses against delta and omicron variants over follow-up times using longitudinal meta-analysis, “Our findings showed a tendency to decrease effectiveness over time based on outcomes and variants” (Mostafavi et al., 2024). After 20 weeks, effectiveness dropped to 93.3 percent for the delta variant. Omicron peak effectiveness was 90.8 percent by week four and dropped to 73.4 percent by week 25. I would use this study to educate patients, specifically immunocompromised patients, on the importance of yearly vaccine booster shots for protection against covid 19(Mostafavi et al., 2024). 

#2

A quantitative analysis of fidgeting in ADHD and its relation to performance and sustained attention on a cognitive task

The study employed a quantitative research design to investigate the relationship between fidgeting and cognitive performance in adults diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). The sample size was adequate but not ideal for the research question. It allowed for a meaningful exploration of the relationship between fidgeting and cognitive performance in adults with ADHD. However, a larger sample would strengthen the study’s external validity. The study analyzed how the independent variable “fidgeting” related to task performance, attentional consistency, and ADHD symptom severity, which were the dependent variables. The study employed valid and reliable instruments to measure the outcomes. Actigraphy devices provide objective and reliable data on fidgeting. Structured interviews and ADHD rating scales are widely validated tools for assessing ADHD symptoms, though self-reports might introduce some bias. The study provides evidence supporting the hypothesis that physical movement during cognitive tasks may serve a functional role in helping individuals with ADHD maintain focus and cognitive control. The study reported statistical significance for its major findings, lending credibility to the relationships between fidgeting, attention regulation, cognitive performance, and ADHD symptom severity. Using the results of this study, I would apply the findings in nursing practice to improve outcomes for patients with ADHD by recognizing the potential benefits of fidgeting as a self-regulation mechanism.

Read the instructions well and use the rubric my picot question and theory are attached 4 pages

My Disease process will be Anemia 

Review the following client scenario: 

Janessa, a 41-year-old female client, presents to the NP complaining of shortness of breath, weakness, and dizziness for “about a month.” She denies having a cough or recent illness. She has a history of endometriosis, and her physical assessment reveals her lungs are clear to auscultation bilaterally, and her mucous membranes are pale.  

Answer all questions/criteria with explanations and detail.  

1. Discuss the underlying pathophysiological mechanisms of your assigned disease process. Which clinical manifestations observed in Janessa’s case could be explained by the pathophysiological mechanisms? 
2. Analyze Janessa’s clinical manifestations in the context of your assigned disease process. Do these findings support a diagnosis of your assigned disease process? Why or why not?  
3. Identify and justify the diagnostic tests (including labs, imaging, or other diagnostic tests) that would be most appropriate for investigating a diagnosis of your assigned disease process in Janessa. What could the results of these tests look like in your assigned disease process? 
4. Compare and contrast your response with a peer who was assigned a different condition. Does their condition fit Janessa’s case? Why or why not? 

All Cite are a scholarly source no older than 5 years.

Hello Dr. G and classmates,

Sickle Cell Disease (SCD) 

The reason I selected Sickle Cell Disease (SCD) as a focus of interest is rooted in my early experiences working in the emergency department. During the beginning of my career, I frequently encountered patients living with SCD, many of whom were experiencing a sickle cell crisis. They sought treatment and relief through IV therapy and pain management. One of the first patients I provided direct care for in the ED had SCD, and the profound pain they endured left a lasting impression on me. This experience deeply affected me, particularly when I noticed the contrasting attitudes that some of my peers held toward patients with SCD. According to Brennan-Cook et al. (2019), caring for patients with SCD in the ED is often challenging and is associated with misconceptions, including negative attitudes and judgments about opioid drug-seeking behavior.

The incidence of SCD in the United States is significant, with 1 in 370 Black or African American births affected, and approximately 1 in every 16,300 Hispanic American births. The total prevalence of SCD is estimated to be around 100,000 individuals in the United States (CDC, 2025).

A relevant article that addresses the care of patients with SCD is “A Pilot Study of Nurse Practitioner’s Perceived Competencies and Attitudes toward Patients Living with Sickle Cell Disease” by Vick et al. This study offers valuable insights into the challenges of treating patients with SCD, specifically during a sickle cell crisis. It highlights the concerns that patients often face when seeking treatment and emphasizes the important role nurse practitioners can play in delivering compassionate and competent care for these individuals.

Reference:

Brennan-Cook, J., Bonnabeau, E., Harris-Bloom, H., & Tanabe, P. (2019). Improving the Care of Individuals with Sickle Cell Disease in the Emergency Department Using a Quality Improvement Framework: The Emergency Department Sickle Cell Assessment of Needs and Strengths (ED-SCANS). Advanced Emergency Nursing Journal, 41(3), 261–270. https://doi.org/10.1097/TME.0000000000000256Links to an external site.

Data and Statistics on Sickle Cell Disease | Sickle Cell Disease (SCD) | CDCLinks to an external site.

Vick, L. L., Mitchell, S., Fernandes, P., Tavakoli, A., Samuels, K., & Jenerette, C. (2024). A Pilot Study of Nurse Practitioners’ Perceived Competencies and Attitudes towards Patients Living with Sickle Cell Disease. Journal for Nurse Practitioners, 20(1), 104829-. https://doi.org/10.1016/j.nurpra.2023.104829Links to an external site.

General question:  What strategies could you implement in your practice to address the unique needs of populations most affected by the condition you have chosen? 

I chose HIV as my disease process